Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery

Study acronym: PEG
StatusCompleted
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Lead sponsor: Centre hospitalier de l'Université de Montréal (CHUM) to Centre hospitalier de l'Université de Montréal (CHUM) Show 6 more changesShow less
    • Primary endpoint(s) modified
    • Trial completed
    • Primary completion date changed from estimate of Sep 1, 2026 to Jul 25, 2025
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoint revised
    • Site details revised
  2. Minor Secondary endpoints: details revised at 1 of 1 entryv2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective is to evaluate the impact of intestinal preparation on the composition, diversity and metabolome of the intestinal microbiota.
Trial Details
NCT Number NCT06831539
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions
(from sponsor)
Cancer, Healthy Participants
Related terms Neoplasms
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov